Des fonds d’investissement exigent des vaccins pour tous

This article for Swiss newspaper Le Temps covers the Access to Medicine Foundation's partnership with nearly 150 investors to call for equitable access to COVID-19 treatments and vaccines.

Ram Etwareea for Le Temps writes about the new investor initiative that calls for a fair and equitable global response to COVID-19 through support for the Access to COVID-19 Tools Accelerator (ACT Accelerator), deeper engagement with healthcare companies and the exploration of new finance mechanisms.

Damiano de Felice, Director of Strategy for the Access to Medicine Foundation, is quoted in the article.

Read the full article here.